Role of tumor markers and cytokines in the pathogenesis of lung cancer
World Journal of Clinical Oncology · 24.06.2026 · 17 (6)
DOI: 10.5306/wjco.121169 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Clinical Oncology, online erschienen am 24.06.2026. Verfasst von Maria Tariq und 6 weiteren Autor:innen. Die Arbeit nennt 106 Literaturangaben.
Abstract (Originalsprache)
Lung cancer is characterized by the uncontrolled proliferation of abnormal cells in one or both lungs, typically originating from the epithelial lining of the airways. Cytokines are small, biologically active proteins that function as signaling molecules, mediating communication between cells and regulating immune and inflammatory responses. In the context of lung cancer, cytokines play a crucial role in modulating the tumor microenvironment and influencing immune responses against malignant cells. Tumor markers and inflammatory cytokines are key contributors to the pathogenesis of lung cancer, facilitating tumor initiation, angiogenesis, and disease progression within an inflammatory microenvironment. Numerous tumor markers and cytokines have been identified and investigated in relation to lung cancer development and progression. However, we focused on carcinoembryonic antigen, squamous cell carcinoma, cytokeratin 19 fragment, tumor necrosis factor-alpha, granulocyte-macrophage colony-stimulating factor, interferon-γ, interleukin (IL)-1, IL-2, IL-4, IL-6, IL-8, IL-10, monocyte chemoattractant protein-1 and neuron-specific enolase in the pathogenesis of lung cancer. Furthermore, they promote immune evasion, epithelial-mesenchymal transition, and metastatic dissemination, thereby serving as important diagnostic, prognostic, and therapeutic targets. These biologically active molecules can modulate the immune response, enhancing the body’s ability to inhibit tumor growth and promote the destruction of lung cancer cells. By stimulating immune effector mechanisms and regulating signaling pathways involved in tumor progression, cytokine-based therapies contribute to improved anti-tumor immunity and represent promising strategies in the management of lung cancer.
Zitieren
APA
Tariq, M., Sattar, A., Khalid, A., Azam, M., Mehmood, M., Hafeez, R., & Rafaqat, S. (2026). Role of tumor markers and cytokines in the pathogenesis of lung cancer. World Journal of Clinical Oncology, 17(6). https://doi.org/10.5306/wjco.121169
Vancouver
Tariq M, Sattar A, Khalid A, Azam M, Mehmood M, Hafeez R, et al. Role of tumor markers and cytokines in the pathogenesis of lung cancer. World Journal of Clinical Oncology. 2026;17(6). doi:10.5306/wjco.121169
BibTeX
@article{Tariq2026,
author = {Tariq, Maria and Sattar, Aqsa and Khalid, Amber and Azam, Minahil and Mehmood, Mehak and Hafeez, Ramsha and Rafaqat, Saira},
title = {Role of tumor markers and cytokines in the pathogenesis of lung cancer},
journal = {World Journal of Clinical Oncology},
year = {2026},
volume = {17},
number = {6},
doi = {10.5306/wjco.121169}
}
EUVIMED